Prof A. Mehta

Ashwin Mehta

Interventional cardiologist / Cardiologist
Jaslok Hospital and Research Centre - Mumbai, India

Latest contributions

DCB and latest DES technology for coronary interventions

22 May 2025 – From EuroPCR 2025

Explore the latest in drug-coated balloon (DCB) and drug-eluting stent (DES) technology for coronary interventions. Review predictors of angiographic outcomes, trial data comparing DCB and DES, and insights into treating calcified lesions and bifurcation disease with novel devices.

DCB and latest DES technology for coronary interventions

Best companions's case on complications in calcified lesions: episode 2

22 May 2025 – From EuroPCR 2025

Join this session examining complex complications in calcified lesion interventions. Learn from cases featuring controversial approaches that successfully resolved issues, coronary perforation management, retrograde iatrogenic dissection after lithotripsy, and algorithmic bailout strategies essential for navigating challenging calcified lesion complications.

Best companions's case on complications in calcified lesions: episode 2

My worst PCI complication: how did I treat and could I have prevented it?

21 May 2025 – From EuroPCR 2025

Learn practical strategies to manage life-threatening PCI complications through real case studies. This session highlights techniques and devices employed to overcome complications, preventive measures, and safe outcome optimization during complex interventions.

My worst PCI complication: how did I treat and could I have prevented it?

Do ultrathin stents improve outcomes?

Do newer generation drug-eluting stents with ultrathin struts improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI)? Join Ashwin Mehta, Upendra Kaul and Anirban Choudhary in a discussion about the TALENT non-inferiority trial, which compared PCI using the Supraflex sirolimus-eluting stent with ultrathin struts with...

Ultrathin stent outcomes

Ability to treat diabetic patients: DES + DCB strategy

23 May 2019 – From EuroPCR 2019

Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Ability to treat diabetic patients: DES + DCB strategy

Crushed, dislodged and compressed: features of complicated stent deployment - Part 1

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to manage complicated stent deployment, thanks to compelling clinical cases, such as: the rescue of malformed left main ostium stent, stent entrapment in the left anterior descending artery, and more!

Crushed, dislodged and compressed: features of complicated stent deployment - Part 1

PCI in cardiogenic shock: learning from real-life cases

21 May 2019 – From EuroPCR 2019

Consult this session on PCI in cardiogenick shock and learn from real-life cases of complex LMCA, STEMI and hemodynamic collapse. Explore the PCI strategies for a patient in cardiogenick shock, the key factors for a successful primary PCI and which mechanical circulatory support you should use in...

PCI in cardiogenic shock: learning from real-life cases